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The influence of pain on neuropsychological test performance has been widely acknowledged (1,2). Many studies have reported that 
executive and attentional functions are affected in chronic pain 
patients, presumably as a result of competing attentional demands of 
chronic pain (2-5). Due to this interruptive nature of pain, it is pre-
sumed that less cognitive resources are available for other processes, 
including cognitive function. Because multiple functions are com-
monly attributed to the concepts of executive and attentional control 
(6), it is one of the most heterogeneous and least well understood 
cognitive domains to date. Furthermore, it is difficult to segregate 
concepts of attention and executive functions at a conceptual level. 
For example, attention encompasses multiple functions including sus-
tained, divided and selective (or focused) attention (6,7), but a strong 
overlap exists between these attentional functions and those that are 
commonly regarded as executive control. This is nicely illustrated by 
tests such as the Trail Making Test (TMT) and the Stroop Colour 
Word task. The TMT part B (8) requires participants to switch 
between different stimuli and to keep track of previously encountered 
items. Hence, this test requires divided attention for successful per-
formance but is commonly regarded as a test of mental flexibility (9). 
The Stroop Colour Word test (10) requires the inhibition of one type 
of stimulus while responding to another stimulus. This test is, there-
fore, commonly regarded as a measure of cognitive inhibition, but it 
also requires the ability to focus attention on one aspect of the task 
while suppressing another aspect, ie, selective attention (6). For the 
sake of clarity, when we refer to a task in the present article, we will 
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BACKGROUND: Diminished executive function and attentional con-
trol has been reported in chronic pain patients. However, the precise pat-
tern of impairment in these aspects of cognition in chronic pain remains 
unclear. Moreover, a decline in psychomotor speed could potentially influ-
ence executive and attentional control performance in pain patients.
OBJECTIVE: To examine different aspects of executive and attentional 
control in chronic pain together with the confounding role of psychomotor 
slowing.
METHODS: Neuropsychological tests of sustained attention, planning 
ability, inhibition and mental flexibility were administered to 34 partici-
pants with chronic pain and 32 control participants.
RESULTS: Compared with the controls, participants with chronic pain 
took longer to complete tests of sustained attention and mental flexibility, 
but did not perform worse on inhibition or planning tasks. The decreased 
performance on the mental flexibility task likely reflects a reduction in 
psychomotor speed. The pattern of performance on the sustained attention 
task reveals a specific decline in attention, indicated by a disproportionate 
decline in performance with an increase in task duration and by increased 
fluctuations in attention during task performance. No additional effect was 
noted of pain intensity, pain duration, pain catastrophizing, depressive 
symptoms, reduced sleep because of the pain or opioid use.
CONCLUSIONS: Executive and attention functions are not uniformly 
affected in chronic pain. At least part of the previously reported decline in 
executive function in this group may reflect psychomotor slowing. Overall, 
limited evidence was found that executive and attention performance is 
indeed lower in chronic pain. Therefore, it can be concluded that in 
chronic pain sustained attention performance is diminished while mental 
flexibility, planning and inhibition appear to be intact.
Key Words: Attention; Chronic pain; Executive function; Pain catastrophizing; 
Pain intensity; Psychomotor speed
La fonction exécutive et l’attention en cas de 
douleur chronique : le rendement est-il 
inversement proportionnel à la charge de travail ?
HISTORIQUE : Chez les patients atteints de douleur chronique, on 
remarque une diminution de la fonction exécutive et du contrôle de 
l’attention. Toutefois, les motifs d’atteinte précis de ces aspects de la cognition 
ne sont pas clairs en cas de douleur chronique. De plus, un ralentissement 
psychomoteur pourrait influer sur le rendement exécutif et le contrôle de 
l’attention chez ces patients.
OBJECTIF : Examiner divers aspects de la fonction exécutive et du contrôle 
de l’attention en cas de douleur chronique de même que le rôle confusionnel 
du ralentissement psychomoteur.
MÉTHODOLOGIE : Les chercheurs ont fait faire des tests neu-
ropsychologiques d’attention soutenue, de planification, de capacités, 
d’inhibition et de flexibilité mentale à 34 participants ayant des douleurs 
chroniques et à 32 sujets témoins.
RÉSULTATS : Par rapport aux sujets témoins, les participants atteints de 
douleur chronique prenaient plus de temps pour effectuer les tests d’attention 
soutenue et de flexibilité mentale, mais n’obtenaient pas de moins bons résultats 
pour ce qui est des tâches d’inhibition ou de planification. Le moins bon rende-
ment en matière de flexibilité mentale reflète probablement une diminution de 
la vitesse psychomotrice. Le motif de rendement à la tâche d’attention soutenue 
révèle une diminution précise de l’attention, indiquée par une diminution dis-
proportionnée du rendement, une augmentation de la durée de la tâche et des 
fluctuations plus marquées de l’attention pendant l’exécution de la tâche. Les 
chercheurs n’ont remarqué aucun effet additionnel sur l’intensité de la douleur, 
la durée de la douleur, la catastrophisation de la douleur, les symptômes dépres-
sifs et la réduction du sommeil à cause de la douleur ou de la prise d’opiacés.
CONCLUSIONS : La fonction exécutive et l’attention ne sont pas unifor-
mément touchées par la douleur chronique. Au moins une partie de la dimi-
nution de la fonction exécutive signalée antérieurement dans ce groupe 
pourrait refléter un ralentissement psychomoteur. Dans l’ensemble, les don-
nées sont limitées pour déterminer que le rendement exécutif et le contrôle de 
l’attention diminuent réellement en cas de douleur chronique. Par con-
séquent, on peut conclure qu’en cas de douleur chronique, l’attention 
soutenue diminue, tandis que la flexibilité mentale, la planification et 
l’inhibition semblent demeurer intactes.
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describe it in terms of the cognitive functions that are most commonly 
used in the research literature, such as inhibition for the Stroop task 
and mental flexibility for the TMT.
The studies to date reveal conflicting findings regarding the precise 
effect of chronic pain on these specific executive and attention func-
tions. Some studies failed to find decreased performance of chronic 
pain patients compared with controls on tasks of inhibition (11,12), 
mental flexibility (12-14) and letter fluency (12). In contrast, other 
studies reported on significant associations between chronic pain and 
inhibition (4), mental flexibility (15,16) and sustained attention 
(5,17). The precise pattern of performance on tasks of executive and 
attention tasks in chronic pain patients thus remains unclear.
A crucial factor that should be considered when examining execu-
tive and attentional task performance in chronic pain patients is 
whether this reflects a specific deficit or a decline in more basic cogni-
tive abilities. More specifically, executive function and attention per-
formance may be particularly vulnerable to a reduction in psychomotor 
speed (6), with psychomotor slowing being a consistent finding in 
chronic pain patients (18). This is an important consideration because 
frequently used tests to assess executive function and attention, such 
as the Stroop Colour Word test and the TMT, are strongly dependent 
on psychomotor speed performance (19-22). A decline in executive or 
attentional performance can therefore only be revealed when an 
increase in task demands substantially affects performance (3), with an 
effect that extends beyond a potential reduction in basic cognitive 
abilities such as psychomotor speed. Some studies attempted to adjust 
for reductions in these abilities by calculating difference scores, for 
example, by subtracting the completion time of different parts of the 
TMT. However, it was recently demonstrated that psychomotor speed 
still significantly contributes to performance on the TMT difference 
score (21). Interestingly, a study that adequately controlled for reduc-
tions in basic cognitive abilities by calculating the interference score 
of the Stroop Colour Word task did not find an effect of chronic pain 
on task performance (12). These findings imply that a decrease in 
executive and attentional task performance may at least be partly 
attributable to a decline in psychomotor speed. In addition, factors 
such as pain catastrophizing and a reduction in sleep quality and opi-
oid use may all influence cognitive functioning (1), and could there-
fore potentially account for the heterogeneous findings regarding 
attention and executive function in chronic pain.
The aim of the present study was to examine the extent to which 
chronic pain affects psychomotor speed, and whether the effects of 
chronic pain on executive and attention functions reflect a decline 
that extends beyond a reduction in this psychomotor slowing. In the 
present study, a repeated measures ANOVA was employed to allow for 
examining disproportional diminished task performance in partici-
pants with chronic pain with increasing task demands or duration (3). 
As such, it could be determined whether group differences on tasks 
represented specific executive and attention impairments. In line with 
previous findings (18), chronic pain participants were expected to 
perform more slowly on the neuropsychological tests. In addition, 
specific lower performance on the attention and executive function 
tests was anticipated (4,5,16,17).
METHODS
Participants
A total of 34 participants with chronic pain were involved in the 
study. Participants with chronic pain were included in cooperation 
with the Pain Clinic at the University Medical Centre Utrecht, the 
Netherlands (n=7), or were participants of a previous (unrelated) 
study (n=9) or were recruited through advertisements (ie, pain inter-
net sites and oral advertising [n=18]). All participants reported persis-
tent pain for >6 months (mean duration 11.7 years, median 6.5 years, 
range one to 50 years). Chronic pain conditions could be categorized 
as visceral pain (n=8), musculoskeletal pain (n=21), neuropathic pain 
(n=3) and other (n=5). Three participants suffered from more than 
one chronic pain condition. The majority of participants with chronic 
pain used pain medication: 17 participants used acetaminophen (para-
cetamol), 13 used a nonsteroidal anti-inflammatory drug (ie, diclofe-
nac, diclofenac plus misoprostol, naproxen, ibuprofen), 11 were 
receiving opioids (ie, tramadol, fentanyl, acetaminophen plus codeine, 
acetaminophen plus tramadol), one used a tricyclic antidepressant 
(amitriptyline) and one used acetaminophen combined with caffeine. 
Four participants did not use any analgesic medication. Current pain 
intensity was rated using a 10 cm visual analogue scale of the Dutch 
translation of the McGill Pain Questionnaire (23). Thirty-two age- 
and IQ-matched control participants were also recruited. All partici-
pants reported to be free of a history of neurodegenerative disorders 
(eg, dementia), stroke, major depressive disorder, and alcohol or other 
substance abuse.
Premorbid IQ was estimated with the Dutch version of the 
National Adult Reading Test (24). Additionally, the Mini Mental 
State Examination (25) was administered to exclude participants with 
possible severe cognitive decline (defined as a score <24). No partici-
pants were excluded on this basis. The characteristics of the partici-
pants are presented in Table 1. Approval for the study was obtained 
from the Medical Ethics Committee of the University Medical Centre 
Utrecht. All participants signed an informed consent form.
Neuropsychological tests
All participants completed four tests to assess executive function and 
attention. First, the Stroop Colour Word test (10) was assessed to 
measure inhibition. This test consists of three cards, namely the Word 
(W) card, the Colour (C) card, and Colour/Word (C/W) card. The W 
card consists of 10 rows with 10 colour names in each row which are 
all printed in black ink. The participant is required to read aloud these 
colour names as fast as possible. For the C card, 10 rows are presented 
containing 10 coloured blocks per row, which the participant is 
required to name as fast as possible. On the C/W card, colour names 
are printed in an incongruent colour, and the participant is required to 
name the colours in which the words are printed as fast as possible. 
The time needed to finish each of the cards was measured. Performance 
on the first two cards reflects basic cognitive abilities such as psycho-
motor speed and reading ability, whereas the third card specifically 
addresses inhibition. To establish diminished inhibition performance 
in chronic pain, a disproportional decline in performance should be 
present on the C/W card, ie, group differences should be more pro-
nounced for the C/W card than for the W and C cards.
Second, the Trail Making Test (8) is a visual search task, measuring 
mental flexibility. The TMT part A consists of 25 encircled numbers 
that are randomly distributed on a sheet of paper. The participant is 
required to connect these numbers sequentially. On the TMT part B, 
both numbers and letters are distributed. This time, the participant is 
instructed to alternate between the numbers and letters (ie, 1, A, 2, B, 
3, etc). Completion times of part A and B were measured. Part A is 
considered to measure basic abilities such as motor speed and visual 
search (19), whereas part B examines mental flexibility. Again, to 
establish whether performance on part B extends beyond a mere 
reduction in basic cognitive abilities in chronic pain, a disproportional 
decline in TMT part B performance in the chronic pain group should 
be present, which extends beyond group differences in TMT part A 
performance.
Third, the Bourdon-Vos test (26) was administered to measure 
sustained attention. This test consists of 33 lines containing groups of 
three, four or five dots presented on a sheet of paper. Participants are 
instructed to cross out the groups with four dots as fast and accurately 
as possible. Completion time and the number of omissions (27) are 
recorded for each line. When only examining the total score (eg, total 
completion time), no information about the ability to sustain atten-
tion can be obtained. Here, a longer completion time might only 
indicate basic cognitive slowing per se, without an impaired ability to 
sustain attention over time. Therefore, the study calculated the aver-
age time to complete a line, and the average number of omissions for 
each line separately for the first one-half of the test (lines 1-17) and 
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the second one-half of the test (lines 18-33). A specific decline in 
sustained attention should be reflected by increased slowing, as well as 
an increased number of omissions, on the second half compared with 
the first half of this test in the chronic pain group. In addition, the 
variability in performance on this task was calculated by examining 
the reaction time and omission scores per row for all 33 rows (28). 
Lower sustained attention performance was indicated by an increased 
variability, reflecting an increase in fluctuations in attention, in the 
completion time and the number of omissions over the different lines 
of the task.
Finally, the Zoo Map test of the Behavioural Assessment of the 
Dysexecutive Syndrome (29) was used to assess planning ability. This 
test consists of an unstructured first part and a structured second part. 
In the first part, participants are instructed to plan their route through 
a map of the zoo, visiting a selection of places while bypassing others. 
While planning the route, participants also need to obey to some rules. 
The second part consists of the same map with the same places that 
have to be visited, only this time instructions are provided about the 
precise order of visits. This second part, therefore, strongly reduces the 
involvement of planning functions. For both cards, the maximum 
score ranged between 0 and 8. Points were deducted if an error was 
made (ie, using a path more than once, deviations from the path, fail-
ure to make a continuous line and inappropriate places visited). Both 
planning and completion time were measured. A specific planning 
problem in chronic pain means that performance (raw score, planning 
or completion time) on the first unstructured card should be dispropor-
tionately affected compared to the second, more structured, card.
Potential confounders
Pain catastrophizing was measured with the Pain Catastrophizing 
Scale (PCS) (30-32), because this may be an important mediator of 
the cognitive impairments observed in chronic pain patients (33,34). 
The Geriatric Depression Scale (GDS) (35) was administered to meas-
ure depressive symptoms, which is a reliable indicator of depressive 
symptoms in both the elderly population and in younger adults 
(36,37). In the chronic pain group, the number of hours lying awake 
because of the pain was also measured with the McGill Pain 
Questionnaire. Finally, the influence of pain duration on performance 
was examined, because an increase in the duration of pain has been 
associated with an increase in brain grey and white matter changes 
(38,39), which likely affect cognitive function.
Procedure
Participants were contacted through the pain clinic, internet sites, oral 
advertising or were participants of a previous study. After informed 
consent was obtained, participants completed a single test session. 
Tests and questionnaires were always administered in the same order: 
participants first completed the questionnaires and then the neuro-
psychological tests (all in a fixed order). A total session lasted approxi-
mately 1 h to 1.5 h.
Statistical analyses
Logarithmic transformation was applied to the TMT part A and B 
completion time measures, and inverse normalizing transformation 
(40) to the Bourdon-Vos omissions (both first half and second half); to 
the attention fluctuations reflected by the variability in completion 
time and omission score of each line of the Bourdon-Vos; and to the 
Zoo Map raw score, the planning and the completion time measures.
A 2×3 mixed-design ANOVA was used for the Stroop Colour 
Word test with group (control versus chronic pain participants) as the 
between-subject factor and completion time of the cards (W, C and 
C/W) as the within-subject factor. A 2×2 mixed-design ANOVA was 
performed for the TMT test, with test version (TMT-A, TMT-B) as 
the within-subject factor and group as the between-subject factor. A 
similar design was employed twice for the Bourdon-Vos test with the 
completion time (first half, second half) and the number of omissions 
(first half, second half) as separate within-subject variables and group 
as a between-subject factor. The variability in completion time and 
omissions of the different lines was analysed using a multivariate 
ANOVA (MANOVA) with group (control versus chronic pain) as 
the independent variable and the completion time and omission vari-
ance as dependent variables. A 2×2 mixed-design was also used for the 
Zoo Map test, where the analyses were run separately for the raw score, 
the planning time and the completion time of both cards. For all 
analyses the study focused on the main effect of group and on the 
interaction between group and the test variables. For all these analyses 
the sphericity assumption (Mauchly’s test), the homoscedasticity 
assumption (Box’s M test) and the homogeneity assumption (Levene’s 
test) were met.
T tests were employed to test for group differences in IQ, age and 
pain catastrophizing. Group differences in depressive symptoms were 
tested with the Mann-Whitney U test because these scores were not 
normally distributed. Sex distribution was examined with a Pearson c² 
test. For these and the above-mentioned tests, the level of significance 
was set at P<0.05.
Pearson correlations were calculated in the chronic pain group 
between current pain intensity, pain duration, pain catastrophizing, 
depressive symptoms and the hours lying awake on the previous night 
because of the pain on the one hand and the cognitive tasks on the 
other. This analysis was performed to examine whether an increase in 
pain severity, duration, depressive symptoms, catastrophizing or a 
reduction in sleep quality was related to a more pronounced decline in 
task performance. Mann-Whitney U tests were performed to examine 
potential group differences in cognitive task performance between 
chronic pain participants who did and did not use opioids. To reduce 
the risk of type I error due to multiple testing, the level of significance 
for the correlational tests was set at P<0.01.
Finally, insufficient effort has been reported in chronic pain 
patients, particularly in those seeking litigation (41,42). These factors 
may result in decreased neuropsychological test performance (43,44). 
To address this possibility, for each patient the present study compared 
their performance on each test to normative data and specifically 
examined the number of participants who performed in the impaired 
range (2 SD or more below average).
RESULTS
The chronic pain and healthy control groups did not differ signifi-
cantly in age (t[64]=0.75, P=0.46), sex (χ2 [1]=2.30, P=0.13) and IQ 
(t[64]=1.88 [P=0.065]) (Table 1). Participants with chronic pain had 
in general higher PCS scores compared with the controls (t[64]= –2.9, 
P<0.01). Depressive symptoms were significantly increased in the 
chronic pain group (Z= –4.58 [P<0.001]). This variable (normalized 
using Blom transformation) was therefore used as a covariate in the 
subsequent repeated measures analyses. The performance of both 
groups on all tasks is presented in Table 2.
Inhibition
No significant main effect for group (F[1, 63]=0.25, P=0.62, η2=0.00) 
or a significant interaction between group and task performance (F[2, 
126]=0.71, P=0.49, η2=0.00) was found on the completion time of the 
Stroop Colour Word test.
Mental flexibility
A significant main effect of group was observed for the TMT (F[1, 
63]=7.74, P<0.01, η2=0.11). Overall, participants with chronic pain 
took longer to complete the TMT part A and part B than the controls. 
However, the interaction between group and task performance was not 
significant (F[1,63]=0.30, P=0.59, η2=0.00), implying that an increase 
in task demands (part B compared with part A) affected performance 
in the chronic pain and the control group to a similar extent.
Sustained attention
A significant main effect of group (F[1,63]=5.28, P<0.05, η2=0.07) was 
found for the completion time of the Bourdon-Vos test, indicating 
that, overall, the chronic pain group took longer to complete this test. 
The interaction between group and task performance was not 
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significant (F[1,63]=0.08, P=0.78, η2=0.00). Analyses of the omissions 
on this test revealed no significant main effect of group (F[1,63]=2.51, 
P=0.12, η2=0.04), but it did reveal a significant interaction effect 
between group and the number of omissions (F[1,63]=5.51, P<0.05, 
η2=0.08). While the control group performed slightly better with 
regard to the number of omissions in the second half compared with 
the first half of this test (t[31]=1.79, P=0.08), a marginally significant 
increase in the number of omissions in the second part of this test was 
found for participants with chronic pain (t[33]= −1.93, P=0.06). 
Finally, a significant effect was found for fluctuations in attention as 
indicated by the variability in the completion time and omission 
scores (F[2,62]=3.15, P<0.05, η2=0.09). Chronic pain patients were 
more variable with regard to the completion time (F[1,63]=5.67, 
P<0.05, η2=0.08), and a marginally significant effect appeared with 
regard to the omissions made on the different lines of this test 
(F[1,63]=3.11, P=0.08, η2=0.05).
Planning
Nearly all participants obtained the maximum raw score on the second 
card (with the exception of two controls and two participants in the 
chronic pain group). The study, therefore, did not analyze the raw 
score of the second card but simply analyzed the raw score of the first 
card with an ANOVA. No significant effect for group was found 
(F[1,62]=0.18, P=0.67, η2=0.00). For the planning time, neither the 
effect of group (F[1,61]=0.54, P=0.47, η2=0.01) nor the interaction 
between group and planning time (F[1,61]=0.01, P=0.91, η2=0.00) 
was significant. The same pattern of results was also obtained for the 
completion time measures, where the main effect of group (F[1,61]=0.03, 
P=0.86, η2=0.00) and the interaction between group and completion 
time (F[1,61]=0.99, P=0.32, η2=0.02) did not reach significance.
Current pain intensity, pain duration and confounders
Current pain intensity ranged between 0 mm and 79 mm on a 0 cm to 
10 cm scale. The correlations between the current pain intensities and 
the cognitive task scores (not including the raw score of the second, 
structured card of the Zoo Map) were all nonsignificant. In addition, 
the cognitive task scores did not correlate significantly with pain dur-
ation, number of hours lying awake, depressive symptoms or the PCS 
scores. Finally, use of opioids was not associated with performance on 
the attention and executive function tests.
Effort to complete tasks
For the Stroop and TMT, age- and education-corrected normative 
data were available. For the Zoo Map test, no normative data were 
available but performance on this test could be converted to a profile 
score. This profile score ranged between 0 and 4. For the current 
analysis, a score of 0 or 1 was defined as impaired, a score of 2 as 
TABLE 1 
Characteristics of the participants
Controls Chronic pain patients
n 32 34
Age, years 55.4±22.0 51.5±20.4
Sex, male/female, n/n 12/20 7/27
IQ 105.4±8.1 101.0±10.6
GDS 3.5±3.6 9.2±5.9*
PCS 13.6±8.2 20.4±10.5*
Current pain, mm – 34.9±23.3
Data for age, IQ, Geriatric Depression Scale (GDS), Pain Catastrophizing 
Scale (PCS) and pain intensity scores are presented as mean ± SD. 
Frequencies are reported for sex distribution. *Significant group difference at 
P<0.05
TABLE 2
Executive and attention task performance in the chronic 
pain and control groups
Control Chronic pain
Stroop
W card (time) 49.0±10.0 47.4±8.3
C card (time) 59.2±9.2 61.8±10.2
C/W card (time) 97.7±24.6 99.4±21.7
TMT
Part A (time) 31.7±9.9 40.3±15.5*
Part B (time) 76.9±27.8 98.0±56.8
Bourdon-Vos
Total time 409.2±85.7 432.8±95.3
   Time first half 12.3±2.6 13.0±2.9
   Time second half 12.5±2.6 13.3±2.9
   Completion time variance 1.8±1.6 2.9±3.1*
Total omissions 10.1±7.9 14.9±15.7
   Omissions first half 0.32±0.26 0.41±0.56
   Omissions second half 0.29±0.26 0.49±0.43*
   Omissions variance 0.32±0.29 0.64±0.87
Zoo Map
Card 1 raw score 4.1±3.1 4.6±3.3
Card 1 planning time 59.5±37.8 74.7±68.2
Card 1 completion time 105.7±67.7 75.4±61.8
Card 2 raw score 7.7±1.0 7.7±1.2
Card 2 planning time 9.6±18.1 7.9±16.6
Card 2 completion time 40.2±17.3 45.6±30.0
Scores presented as mean ± SD. The Bourdon first and second half indices 
represent the average performance (completion time or omissions) per line (of 
a total of 33 lines). The variance indices represent the variance in either 
completion time or omissions across the 33 lines of the Bourdon-Vos test. 
*Significant group differences at P<0.05 as indicated with t tests (using nor-
malized scores for the TMT variables, the Bourdon-Vos total omissions and 
variance in completion time and omissions, as well as all Zoo Map variables). 
C Colour; C/W Colour/word; W Word; TMT Trail Making Test
TABLE 3
Prevalence of impaired neuropsychological task 
performance in the control and chronic pain groups
Controls (n=32)
Chronic pain 
(n=34) P
Stroop
   W card 3 (9.4) 1 (2.9) 0.35
   C card 1 (3.1) 0 (0.0) 0.49
   C/W card 0 (0.0) 0 (0.0) –
TMT
   Part A 0 (0.0) 2 (5.9) 0.49
   Part B 0 (0.0) 4 (11.8) 0.11
Bourdon completion time 3 (9.4) 5 (14.7) 0.71
Bourdon omissions 1 (3.1) 3 (8.8) 0.61
Zoo Map 0.61
   Profile score 0 or 1 0 (0.0) 1 (3.0)
   Profile score 2 10 (31.3) 11 (33.3)
   Profile score 3 or 4 21 (65.5) 21 (63.6)
Total impaired tests 0.23
   0 27 (84.4) 24 (70.6)
   1 3 (9.4) 5 (14.7)
   2 1 (3.1) 5 (14.7)
   3 1 (3.1) 0 (0.0)
   >3 0 (0) 0 (0)
Data represent the number of participants, n (%), who performed in the 
impaired range (−2 SD), with the exception of the Zoo Map profile and Total 
impaired tests scores, which represent the number (%) of participants who 
obtained that score. P values represent the outcome of χ² tests to test for 
group differences. C Colour; C/W Colour/word; W Word; TMT Trail Making 
Test
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borderline intact, and a score of 3 or 4 as intact. Finally, no normative 
data were available for adults for the Bourdon-Vos test either. 
Previously published results of controls (31) were used to determine 
potential below average performance in the participants.
Because few participants demonstrated impaired performance on 
one or more tests, Fisher’s exact testing was used to examine potential 
differences between these frequencies, except for the Zoo Map where 
three outcome options were tested (Table 3). In addition, the total num-
ber of tasks on which the participants performed in the impaired range 
were examined. No group differences were found on any of these out-
come measures. Additional Kruskal-Wallis testing, in which the total 
number of tasks on which performance was impaired were defined as 
none (n=51), one (n=8) and two or more (n=7), revealed that an 
increase in the number of impaired tasks was associated with higher age 
(c²[2]=8.16, P<0.05) and lower estimated IQ (c²[2]=11.85, P<0.01).
DISCUSSION
The present study investigated executive and attentional functions in 
chronic pain while taking reductions in psychomotor speed into 
account. The findings demonstrate that participants with chronic pain 
perform worse than controls on tests of mental flexibility and sustained 
attention, but not on inhibition or planning ability. With regard to the 
mental flexibility task and the completion time of the sustained atten-
tion test, we did not find evidence that performance of the partici-
pants with chronic pain was disproportionately affected with increasing 
task load. This indicates that the decline in performance on these 
tasks is more likely the net result of psychomotor slowing. Notably, 
however, the results on the sustained attention task indicate that 
chronic pain patients have decreased attentional functioning. More 
omissions on the second part of the sustained attention task were made 
compared with the first part, whereas the opposite pattern was 
observed in the control group. Also, the chronic pain group revealed 
increased fluctuations in attention, as indicated by an increased vari-
ability in completion time and omissions across the different lines of 
the task. To summarize, several executive and attentional functions 
(ie, mental flexibility, planning and inhibition) appear to be largely 
intact in chronic pain except for a specific decline in the ability to 
sustain attention.
In the present study, we found intact inhibition, which is in agree-
ment with previous studies on selective attention or inhibition in this 
patient group (11,12). For the planning test, little is known about the 
potential disruptive effects of chronic pain on task performance. To 
our knowledge, we are the first to examine this function in chronic 
pain and show that planning is still intact in this group. Our study 
findings are further in line with previous studies that demonstrated 
diminished performance on sustained attention and mental flexibility 
tasks in chronic pain patients. Sjøgren et al (5) examined neuro-
psychological functioning of chronic pain patients on a sustained 
attentional performance reaction time test in which patients had to 
respond as fast as possible to auditory signals delivered over a 10 min 
period. The authors found longer reaction times for patients compared 
with controls for this test. Interestingly, they also found lower perform-
ance of the chronic pain patients on a finger tapping task, measuring 
motor speed. It thus remains unclear from these findings whether sus-
tained attention was affected independently of diminished speed or 
whether the slower reaction times on the auditory reaction time test 
were due to impairments in speed in this patient group. The same 
holds for the study by Wiener et al (45). These authors demonstrated 
decreased performance on part B of the TMT in older chronic pain 
patients, but performance on a test for fine motor performance (the 
Grooved Pegboard) was also diminished in this patient group. Also in 
that study it remained unclear whether mental flexibility was affected 
or whether psychomotor slowing could explain the findings. The 
present study is the first to indicate that slowing on a task of mental 
flexibility may be due to reductions in basic cognitive functions, 
whereas difficulties in sustaining attention may be independent of 
these processes.
The mechanisms for the decline in attention and executive func-
tion in chronic pain patients remain largely unclear. Several different 
hypotheses have been postulated to explain reduced cognitive, and in 
particular attentional, functions in chronic pain patients. It has been 
argued that patients have an attentional bias toward painful sensations 
which may cause distraction from other stimuli. In a recent study, rats 
with monoarthritis caused by complete Freund’s adjuvant showed a 
marked decline in a sustained attention task (five-choice serial reac-
tion time task) (46). After pain was induced, rats were less accurate 
and made more omissions on this task. Interestingly, this decline in 
performance was not altered by transient analgesic drug administra-
tion, indicating that distraction due to pain is probably not the main 
cause of attentional deficits in chronic pain.
Another hypothesis is that attention and pain share common 
resources (47). The experience of pain may reduce the capacity to 
attend to another stimulus because it captures attentional resources 
itself. In this perspective, it is expected that with increasing task 
demands cognitive task performance decreases disproportionally in 
chronic pain patients. Our results are not completely in line with this 
view because such a specific pattern of results was not observed for 
three different executive function tests. An alternative perspective 
proposes that perhaps attentional capacity is not impaired in chronic 
pain, but chronic pain patients have the tendency to allocate atten-
tion differently (48,49). An attentional bias toward stimuli, especially 
pain, has been described by the hypervigilance perspective. Recent 
data suggest that allocation of attention is different in chronic pain 
patients, and not necessarily only when pain-related information is 
involved (49). It seems reasonable to assume that the allocation of 
attention is particularly sensitive to long durations over time. Our 
present finding that participants with chronic pain have a specific dif-
ficulty in sustaining attention might therefore potentially reflect an 
underlying problem in the allocation of attention.
Increasing pain severity has been previously found to be associated 
with decreased cognitive task performance (3,45,50). For example, 
Grisart and Plaghki (4) found that selective attention or inhibition, as 
assessed with the Stroop Colour Word task, was affected in chronic 
pain patients, but only in patients with pain of high intensity with a 
visual analogue scale score of 60 or more. In the present study, no sig-
nificant association was observed between pain severity and perform-
ance on the neuropsychological tasks. Potentially, the level of pain 
intensity in our chronic pain sample was not severe enough to repli-
cate the previously observed associations between pain intensity and 
cognitive task performance. Future studies on the pattern of atten-
tional task performance in chronic pain patients could consider 
including patients with higher pain intensity levels. It is possible that 
the specific decline in task performance with increasing task demands 
is present in chronic pain patients with high pain intensity levels.
One potential limitation of our study is that we included a hetero-
geneous sample of participants with chronic pain. The extent to which 
this explains the absence of a specific executive deficit in our sample is 
unclear. However, in a previous study with the same heterogeneous 
patient sample, we were able to find significantly lower performance 
on multiple memory tests (50). Nevertheless, the current results 
should be replicated in more homogeneous patient samples.
Also, the attention and executive function domains cover multiple 
aspects of cognition, some of which were not addressed in the current 
study. For example, working memory and set shifting have also been 
denoted as aspects of executive function (6), while others have tried to 
differentiate between alerting, orienting and executive attention (51). 
Only several indices of attention and executive function were exam-
ined in the present study; future studies are therefore needed to obtain 
a more complete assessment of the executive and attention domains.
A final point of consideration concerns the high variability in 
performance on some of the tests (eg, the TMT-B and the Zoo Map 
test) in the chronic pain group. This could possibly reflect low validity 
of these tests, but an increase in variances in test performance has 
often been reported in different clinical groups (52,53). The 
Oosterman et al
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